Healthcare AI Acquisition Corp.
Status: Live Deal
U=S+W/2
W=S@11.50
| IPO Proceeds, $M | $215.62M |
|---|---|
| IPO Date | Dec 10, 2021 |
| CEO | Jiande Chen |
| Left Lead | Citigroup |
| IPO Cash in Trust | 102.0% |
| SPAC Tenor | 18 + 12 + 6 |
| IPO Sector |
Healthcare
Businesss in the healthcare and pharmaceutical sector with technological transformation potential |
| IPO Geography | Global |
| Target Company | Leading Group |
| Deal Announced | Aug 15, 2024 |
| Deal Size, $M | $531.00M |
| Deal Sector | Financial |
| Deal Geography | Asia |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | Nov 26, 2024 |
HAIA
HAIAU
HAIAW
| Price | $11.50 |
|---|---|
| Last closing price | $11.44 |
| H/L, 52-week | $10.12 / $11.48 |
| Volume, today | 994 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Healthcare AI Acquisition Corp.:
- Structure and cap table
- 5 directors & officers
- 28 filings and events
- 2 underwriters
- 6 deal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Jiande Chen | Chief Executive Officer | |
| Xiaocheng Peng | CFO & Director | |
| Nat Y Chan | Director | |
| Stefan Dodov | Director | |
| Manuel C. Menendez III | Director |
Sign in to view team biographies and more sponsor and affiliate data.